Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients (Q73230710)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

J Drulović

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Mostarica-Stojković

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Z Lević

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Stojsavljević

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

V Pravica

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Mesaros

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

145-150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

The adhesion molecule and cytokine profile of multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

The role of genetic factors in multiple sclerosis susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

T-cell autoimmunity in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Benign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Exacerbations of multiple sclerosis in patients treated with gamma interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Tumour necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Enhanced interferon-gamma-induced Ia-antigen expression by glial cells after previous exposure to this cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

The role of IL-12 in the induction of organ-specific autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Interleukin-12 and its role in the generation of TH1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905320-8

10.1016/S0022-510X(96)05320-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9106119%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference